International Psoriasis Council
Calendar & Events
Continuing Medical Education
The International Psoriasis Council is pleased to bring you the following continuing medical education (CME) opportunities to advance your knowledge of treating patients with psoriasis.
Each of these activities have been planned in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education (ACCME.
-
Advancing the Art and Science of Psoriasis and Psoriatic Arthritis : This educational initiative was prepared with content expertise provided by Program Chair Alan Menter, MD; Jerry Bagel, MD; Kenneth B. Gordon, MD; Kristine Kucera, DHS, MPAS, PA-C; and Melodie Young, MSN, RN, A/GNP-C.
This educational initiative is provided by: Curatio CME Institute, University of Chicago, Dermatology Nurse's Association, and the SDPA.
In partnership with: International Psoriasis Council and the National Psoriasis Foundation.
CME/CE Clinician Educator (pocket reference guide)
The pocket guide is a practical reference guide for use in your clinical practice.
• Side A discusses treatment recommendations based on disease severity, location of disease, and other patient characteristics and delineates key clinical considerations for the use of traditional and biologic systemic therapy
• Side B addresses many patient questions and concerns about psoriatic disease and should be a useful resource in your consultations with patients
View online or request a copy
CME/CE Biologic Bulletin
This Biologic Bulletin has been designed to provide everyone involved in the care of psoriasis patients with an overview of treatment recommendations based on guidelines published by the American Academy of Dermatology.
View online or request a copy
CME/CE iPhone App
The iPhone app includes an algorithm for informing treatment decisions and provides information about the traditional systemic and biologic agents used in the management of psoriatic disease.
Coming soon to iTunes -
IPC Psoriasis Review – 2011 Summer Issue : This issue of the IPC Psoriasis Review presents a review of the Clinical & Scientific Advances from the American Academy of Dermatology’s 69th Annual Meeting held in New Orleans, Louisanna and is available for CME credits.
Format: Monograph Credit Designation: 1.0 credit(s) Expiration Date: September 21, 2012
Program Overview The goal of this program is to provide important clinical and scientific data on the treatment of psoriasis.
Target Audience
This activity has been designed to meet the educational needs of dermatologists and health care providers involved in the care of patients with psoriasis.
Learning Objectives
Upon completion of this activity, participants will be able to: 1) Review and analyze the benefit to risk differences between approved psoriasis therapeutic agents and incorporate these into clinical practice 2) Discuss the relative mechanisms of action of approved therapies and those in clinical development 3) Apply knew knowledge and learning to practice techniques to more effectively and optimally manage the patient
Physician Accreditation Statement
This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of Purdue University College of Pharmacy, the International Psoriasis Council and Focus Medical Communications. Purdue University College of Pharmacy, an equal access/equal opportunity institution, is accredited by the ACCME to provide continuing medical education for physicians.
Credit Designation
Purdue University School of Pharmacy designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit (s)TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Disclosure Statement
All faculty and staff involved in the planning or presentation of continuing education activities sponsored/ provided by Purdue University College of Pharmacy are required to disclose to the audience any real or apparent commercial financial affiliations related to the content of their presentation or enduring material. Full disclosure of all commercial relationships must be made in writing to the audience prior to the activity. Focus Medical Communications staff, International Psoriasis Council staff and Purdue University College of Pharmacy staff have no relationships to disclose.
Dr. Firas Al-Niaimi
Dr. Firas Al-Niaimi has not served as an investigator, speaker or consultant for any pharmaceutical companies.
Dr. Kenneth Gordon
Dr. Kenneth Gordon has grant/research support from Abbott, Amgen, Centocor, Pfizer and Celgene. He has served as a consultant to Abbott, Amgen, Centocor, Pfizer, Novartis and Merck.
Dr. Murlidhar Rajagopalan
Dr. Murlidhar Rajagopalan has been a consultant for MSD, Schering Plough and an advisory board member and honorarium recipient from Pfizer (Wyeth).
Accredited by:
Purdue University Program Sponsored By:
This material was supported by an educational grant from Abbott, Amgen and Janssen Biotech, Inc.